{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:09:28Z","timestamp":1767146968472,"version":"build-2238731810"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jep.2015.01.013","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T11:53:25Z","timestamp":1421668405000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice"],"prefix":"10.1016","volume":"163","author":[{"given":"Nandani Darshika","family":"Kodithuwakku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-dong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-rong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2015.01.013_bib1","doi-asserted-by":"crossref","first-page":"26834","DOI":"10.1074\/jbc.C800156200","article-title":"Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans","volume":"283","author":"Anzai","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.jep.2015.01.013_bib2","doi-asserted-by":"crossref","first-page":"F612","DOI":"10.1152\/ajprenal.00139.2009","article-title":"Mouse GLUT9: evidences for a urate uniporter","volume":"297","author":"Bibert","year":"2009","journal-title":"American Journal of Physiology \u2013 Renal Physiology"},{"key":"10.1016\/j.jep.2015.01.013_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.jep.2015.01.013_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/meta.2001.26705","article-title":"Clinical features of familial gout and effects of probable genetic association between gout and its related disorders","volume":"50","author":"Chen","year":"2001","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.jep.2015.01.013_bib5","series-title":"Pharmacopoeia of the People\u05f3s Republic of China","first-page":"50","author":"Chinese Pharmacopoeia Committee","year":"2005"},{"key":"10.1016\/j.jep.2015.01.013_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.jep.2015.01.013_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11095-005-2486-x","article-title":"Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats","volume":"22","author":"Deguchi","year":"2005","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.jep.2015.01.013_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ndt\/16.5.1042","article-title":"Screening for renal disease using serum creatinine: who are we missing?","volume":"16","author":"Duncan","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.jep.2015.01.013_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clinical and Experimental Nephrology"},{"key":"10.1016\/j.jep.2015.01.013_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.jrn.2006.10.013","article-title":"The role of uric acid in pediatric hypertension","volume":"17","author":"Feig","year":"2007","journal-title":"Journal of Renal Nutrition: The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"key":"10.1016\/j.jep.2015.01.013_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1054-3589(08)60098-8","article-title":"Uricosuric drugs, with special reference to probenecid and sulfinpyrazone","volume":"4","author":"Gutman","year":"1966","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.jep.2015.01.013_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.jep.2015.01.013_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.jep.2015.01.013_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.jep.2015.01.013_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.jep.2015.01.013_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0960-894X(01)00093-2","article-title":"Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors","volume":"11","author":"Ishibuchi","year":"2001","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.jep.2015.01.013_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3181\/00379727-131-33791","article-title":"Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria","volume":"131","author":"Johnson","year":"1969","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.jep.2015.01.013_bib18","doi-asserted-by":"crossref","first-page":"F679","DOI":"10.1152\/ajprenal.2000.279.4.F679","article-title":"Localization of organic cation transporters OCT1 and OCT2 in rat kidney","volume":"279","author":"Karbach","year":"2000","journal-title":"American Journal of Physiology \u2013 Renal Physiology"},{"key":"10.1016\/j.jep.2015.01.013_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jep.2013.10.016","article-title":"Anti-inflammatory and antinociceptive effects of Chinese medicine SQ gout capsules and its modulation of pro-inflammatory cytokines focusing on gout arthritis","volume":"150","author":"Kodithuwakku","year":"2013","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.jep.2015.01.013_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","article-title":"Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia","volume":"83","author":"Matsuo","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.jep.2015.01.013_bib21","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/srep03755","article-title":"ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload","volume":"4","author":"Matsuo","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/j.jep.2015.01.013_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1080\/15257770.2011.627902","article-title":"Identification of ABCG2 dysfunction as a major factor contributing to gout","volume":"30","author":"Matsuo","year":"2011","journal-title":"Nucleosides, Nucleotides & Nucleic Acids"},{"key":"10.1016\/j.jep.2015.01.013_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/dmd.107.019869","article-title":"Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia\/reperfusion-induced acute kidney injury","volume":"36","author":"Matsuzaki","year":"2008","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.jep.2015.01.013_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/bpb.30.1551","article-title":"Hypouricemic action of selected flavonoids in mice: structure-activity relationships","volume":"30","author":"Mo","year":"2007","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.jep.2015.01.013_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ndt\/gfr530","article-title":"Serum uric acid and chronic kidney disease: the Severance cohort study","volume":"27","author":"Mok","year":"2012","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.jep.2015.01.013_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.jep.2015.01.013_bib27","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1248\/bpb.28.2231","article-title":"Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats","volume":"28","author":"Nguyen","year":"2005","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.jep.2015.01.013_bib28","unstructured":"Province(Ed.), P.C.o.H., 2009. Pharmacopoeia of Hunan Traditonal drug 8,218."},{"issue":"3","key":"10.1016\/j.jep.2015.01.013_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.jep.2015.01.013_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.jep.2015.01.013_bib31","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jep.2015.01.013_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0031-6989(75)80015-4","article-title":"Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate","volume":"7","author":"Stavric","year":"1975","journal-title":"Pharmacological research communications"},{"key":"10.1016\/j.jep.2015.01.013_bib32","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3899\/jrheum.081128","article-title":"The prevalence of nephrolithiasis in patients with primary gout: a cross-sectional study using helical computed tomography","volume":"36","author":"Shimizu","year":"2009","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.jep.2015.01.013_bib33","unstructured":"State Pharmacopoeia Commission of People\u05f3s Republic of China (Ed.), 2010. Pharmacopoeia of People\u05f3s Republic of China. 11,136,152"},{"key":"10.1016\/j.jep.2015.01.013_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1742-7843.2004.pto940506.x","article-title":"Administration of Procyanidins from Grape Seeds Reduces Serum Uric Acid Levels and Decreases Hepatic Xanthine Dehydrogenase\/Oxidase Activities in Oxonate\u2010Treated Mice","volume":"94","author":"Wang","year":"2004","journal-title":"Pharmacology & Toxicology"},{"key":"10.1016\/j.jep.2015.01.013_bib34","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1214530110","article-title":"Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules","volume":"110","author":"Woodward","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jep.2015.01.013_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ki.2010.206","article-title":"A \u05f3complexity\u05f3 of urate transporters","volume":"78","author":"Wright","year":"2010","journal-title":"Kidney International"},{"key":"10.1016\/j.jep.2015.01.013_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc11-1346","article-title":"Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function","volume":"35","author":"Zoppini","year":"2012","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/j.jep.2025.119824","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000}}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874115000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874115000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T21:07:48Z","timestamp":1651007268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874115000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"alternative-id":["S0378874115000288"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2015.01.013","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2015.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}